Novavax Inc at JPMorgan Healthcare Conference Transcript
&-
I am Eric Joseph, senior biotech analyst at JPMorgan and our next presenting company is Novavax. Presenting on behalf of the company is CEO, John Jacobs. There is going to be a Q&A session after the presentation. So just raise your hand, we'll bring a mic around for those who have questions. And for those tuning in via webcast, you can submit questions there as well. So with that, John.
Thank you, Eric. Good evening everyone. Thank you for joining us tonight at this late hour. So we're probably standing between you and dinner and a cocktail or for some of you that I know maybe a good cigar and that kind of thing. But really appreciate you joining us this evening.
I'm CEO of Novavax, John Jacobs, and I'm joined tonight by several colleagues who will be joining me for the Q&A session. Dr. Filip Dubovsky, our President of R&D; John Trizzino, our President and Chief Operating Officer; and Jim Kelly, our CFO
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |